Publications
2023
Kalafatis, Eleftherios, Mitsis, Konstantinos, Zarkogianni, Konstantia, Athanasiou, Maria, Voutetakis, Antonis, Nicolaides, Nicolas, Chatzidaki, Evi, Polychronaki, Nektaria, Chioti, Vassia, Pervanidou, Panagiota, Perakis, Konstantinos, Antonopoulou, Danae, Papachristou, Efi, Kanaka-Gantenbein, Christina, Nikita, Konstantina S.. “Artificial Intelligence Based Procedural Content Generation in Serious Games for Health: The Case of Childhood Obesity”. Wireless Mobile Communication and Healthcare, pp. 207--219, 2023.
2022
Vasilakis, I. A., Kosteria, I., Papavasileiou, G., Zarkogianni, K., Kalafatis, L., Mitsis, K., Athanasiou, M., Perakis, K., Taliou, A., Nicolaides, N., Chioti, V., Tokou, I., Vergeti, D., Antonopoulou, D., Papachristou, E., Meklis, V., Nikita, K., Kanaka-Gantenbein, C.. “The ENDORSE feasibility pre-pilot trial: Assessing an innovative integrated platform, implementing serious games strategy and artificial intelligence-based telemedicine for glycemic control improvement”. Pediatric Diabetes, pp. 65--65, 2022.
Vasilakis, I. A., Kosteria, I., Mitsis, K., Zarkogianni, K., Kalafatis, L., Athanasiou, M., Perakis, K., Papavasiliou, G., Taliou, A., Nicolaides, N., Chioti, V., Tokou, I., Vergeti, D., Antonopoulou, D., Papachristou, E., Meklis, V., Nikita, K., Kanaka-Gantenbein, C.. “THE ENDORSE FEASIBILITY PILOT TRIAL: ASSESSING THE IMPLEMENTATION OF SERIOUS GAMES STRATEGY AND ARTIFICIAL INTELLIGENCE- BASED TELEMEDICINE IN GLYCEMIC CONTROL IMPROVEMENT”. Diabetes Technology and Therapeutics, pp. A218--A219, 2022.
2021
Zarkogianni, K, Athanasiou, M, Mitsis, K, Vasilakis, I, Kosteria, I, Perakis, K, Vergeti, D, Antonopoulou, D, Papachristou, E, Chioti, V, others. “The Endorse Pilot Trial”. Diabetes Technology & Therapeutics, pp. A68--A68, 2021.
Zarkogianni, K, Athanasiou, M, Mitsis, K, Chatzidaki, E, Polychronaki, N, Perakis, K, Vergeti, D, Antonopoulou, D, Papachristou, E, Chioti, V, others. “A Comprehensive Approach To Empower Self-Management of Health in Childhood Obesity Based on Gamification Mechanisms and Biofeedback”. Diabetes Technology & Therapeutics, pp. A57--A58, 2021.